![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 19, 11413-11416, May 8, 1998
,
¶,
, and
From the
Max-Planck-Institut für medizinische
Forschung, Abteilung Biophysik, Jahnstrasse 29, 69120 Heidelberg,
Germany, § Max-Planck-Institut für molekulare
Physiologie, Abteilung Physikalische Biochemie, Rheinlanddamm 201, 44139 Dortmund, Germany, and
Biochemie-Zentrum Heidelberg,
Ruprecht-Karls Universität, Im Neuenheimer Feld 501, 69120 Heidelberg, Germany
| |
ABSTRACT |
|---|
|
|
|---|
Peptide deformylase is an essential metalloenzyme required for the removal of the formyl group at the N terminus of nascent polypeptide chains in eubacteria. The Escherichia coli enzyme uses Fe2+ and nearly retains its activity on substitution of the metal ion by Ni2+. We have solved the structure of the Ni2+ enzyme at 1.9-Å resolution by x-ray crystallography. Each of the three monomers in the asymmetric unit contains one Ni2+ ion and, in close proximity, one molecule of polyethylene glycol. Polyethylene glycol is shown to be a competitive inhibitor with a KI value of 6 mM with respect to formylmethionine under conditions similar to those used for crystallization. We have also solved the structure of the inhibitor-free enzyme at 2.5-Å resolution. The two structures are identical within the estimated errors of the models. The hydrogen bond network stabilizing the active site involves nearly all conserved amino acid residues and well defined water molecules, one of which ligates to the tetrahedrally coordinated Ni2+ ion.
| |
INTRODUCTION |
|---|
|
|
|---|
In eubacteria as well as in mitochondria and chloroplasts the amino group of methionyl-tRNAfMet is N-formylated by a formyltransferase during initiation of protein synthesis (1). Consequently, all nascent polypeptides are synthesized with N-formylmethionine at the N terminus. During elongation of the polypeptide chain the formyl group is removed hydrolytically by the enzyme peptide deformylase (PDF,1 EC 3.5.1.27) (2, 3). For Escherichia coli, deletion of the formyltransferase gene leads to a strongly reduced cell growth rate (4), whereas deletion of the PDF gene proves lethal (5). This formylation/deformylation cycle, which appears to be a characteristic feature of eubacteria, does not occur in the cytoplasm of eucaryotic cells. Therefore, PDF is an attractive target for the design of new antibiotics.
PDF from E. coli, a monomeric protein of 168 residues, shares the fingerprint motifs HEXXH (6), EGCLS, and GXGXAAXQ (7) with PDF sequences of other eubacteria, which suggests a common architecture of the catalytic region in these proteins. PDF was reported to be a zinc enzyme (8) that contains the motif HEXXH, known to be involved in zinc binding in metalloproteases (9, 10). Meanwhile, it has been shown that PDF utilizes Fe2+ as catalytic metal whereas the Zn2+ form is nearly inactive (11, 12). Interestingly, Fe2+ can be replaced by Ni2+ with a slight reduction in PDF activity (11).
Recently, the structure of the core domain (residues 1-147) of PDF was solved by NMR (8) and the structure of the full-length protein by x-ray crystallography at 2.9-Å resolution (13). Both structures describe the protein as isolated with a tightly bound zinc ion. We report the structure of the catalytically active enzyme in the nickel-bound form (PDF-Ni) at 2.5-Å resolution and at 1.9-Å resolution in complex with a polyethylene glycol molecule (PDF-Ni/PEG), shown here to be a competitive inhibitor of the enzyme.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
PDF-Ni (specific activity, 900 units/mg; 0.6 Ni2+ ions per protein molecule) was isolated from overproducing E. coli cells and crystallized with 2 M (NH4)2SO4 as precipitant in the presence of 1% (w/v) PEG-1000 as described.2 Crystals were washed in 100 mM MOPS/NH3, 1% (w/v) PEG-1000, 2 M (NH4)2SO4 at pH 7.4. Three isomorphous derivatives were obtained by soaking crystals in the above buffer with added heavy atom compounds. The mercury derivative crystals were harvested after soaking 12 h in 0.1 mM ethylmercury phosphate (EMP), the platinum derivative after soaking 24 h in 2 mM K2PtCl4, and the double derivative after soaking 24 h in 0.1 mM CH3HgCl and 2 mM K2PtCl4. PDF-Ni crystals without PEG have been described.2
Diffraction data were collected at room temperature by the
rotation method and recorded by an electronic area detector (x-rays: CuK
, focused by Franks double-mirror optics; generator:
GX-18, Elliot/Enraf-Nonius, Delft, operated at 35 kV/50 mA; detector: X100, Siemens/Nicolet, Madison, WI; crystal to detector distance: 10 cm; rotation/image: 0.0417° or 0.0833°). Integrated intensities were extracted from the rotation images by the program XDS (15), which
includes routines for space group determination from the observed
diffraction pattern (16).
Inhibition of PDF by PEG-1000 was determined by the following
procedure. PDF activity was measured at 30 °C with formyl-Met (1-32
mM) at pH 7.2 (100 mM MOPS/NaOH, 2 M
Li2SO4, 1 mM TCEP) in a total
volume of 50 µl. The reaction was started by 420 ng of PDF-Ni (5 µl) and stopped after 5 min by 4% HClO4 (50 µl). The
amount of hydrolyzed substrate was determined according to the method
of Fields (17) using 2,4,6-trinitrobenzolsulfonic acid
(
420 = 22 mM
1
cm
1). For inhibition studies, up to 10 mM
PEG-1000, pretreated with TCEP (350 mM PEG/35
mM TCEP, pH 7.2) for 1 h, was included in the assay
mixture. Vmax and apparent KM
values were estimated from double-reciprocal plots (1/v
versus 1/[S]), and the KI value was
calculated from secondary replots of the slopes versus
PEG-1000 concentrations.
| |
RESULTS |
|---|
|
|
|---|
Structure Determination--
Crystallographic data used for
structure determination are summarized in Table
I. The structure of PDF-Ni/PEG crystals
was solved by the multiple isomorphous replacement method and
exploitation of the 3-fold redundancy of the electron density in the
asymmetric unit. The atomic model was obtained by several rounds of
model building (18) and correction followed by refinement (19) and map
calculation. Atomic coordinates for about 50% of the residues were
restrained to obey non-crystallographic symmetry. Unexpected density
near the metal ion occurred in all three independent monomers and
improved to a clear feature during the refinement process. It was then
assumed to be an ordered part of a PEG molecule, consistent with
subsequent biochemical studies showing that PEG is a competitive inhibitor of PDF. Only parts of the PEG-1000 molecules
(HO(C2H4O)nH,
= 22) are found in the map at a density above 5% of the map
maximum. The visible part is modeled with n = 10 for
the molecule length. The final model consists of 4122 (3 × 1346 + 84 alternate locations) non-hydrogen protein atoms, 3 Ni2+
ions, 2 SO42
ions, 3 PEG, and 205 water molecules. The estimated coordinate error is 0.21 Å, and r.m.s.
deviations from ideal geometry are 0.01 Å and 1.2° for bond length
and bond angles, respectively.
|
ions, and 100 water molecules.
The estimated coordinate error is 0.30 Å, and r.m.s. deviations from
ideal geometry are 0.015 Å and 1.4° for bond length and bond angles,
respectively. In both structures, coordinates for residues Arg-167 and
Ala-168 are ill defined, and Pro-9 is found in a
cis-conformation.
Overall Structure--
Basically confirming the results of Chan
et al. (13), PDF-Ni is an
+
protein consisting of a
five-stranded antiparallel
-sheet (
1,
2,
3,
6,
7), a two-stranded
-ribbon (
4,
5), three regular
-helices, and three short
310 helices (Figs. 1 and
2). It has been noticed (8) that this
overall arrangement of secondary and tertiary structure is quite
different from other metalloproteases such as thermolysin (20) or
stromelysin-1 (21), which also contain parallel
-strands.
|
|
atoms is 0.25 Å (residues 66-68 and 161-168 are omitted from the comparison), which
is within the expected coordinate errors of the models. The monomer
structure is apparently rigid and structurally insensitive to the
binding of PEG and to different environments in the crystal.
Active Site--
Sequence alignment of deformylases from other
eubacteria reveals three conserved regions,
G43XGXAAXQ,
E88GCLS (7), and H132EXXH, which are believed
to form the catalytic site of the enzyme involved in metal and
substrate binding. Our electron density map at 1.9-Å resolution allows
an unambiguous assignment of all non-hydrogen atoms forming the active
site (Fig. 3). As reported for the zinc
structures (8, 13), the Ni2+ ion is found to be
tetrahedrally ligated (for review of metal liganding see Ref. 22) to
the N-
2 atoms of His-132 and His-136 in the HEXXH motif,
to the S-
atom of Cys-90, and to an oxygen atom of the group W1
modeled as a water molecule (Figs. 4 and 5). All four ligands are precisely
aligned by an intricate network of hydrogen bonds involving conserved
residues of the enzyme family. The side chain of His-132 forms a
hydrogen bond with the side chain of Glu-88, which itself is fixed by
Arg-102 and indirectly by Asp-135. His-136 is held in place by Leu-13
mediated by a water molecule W3. The fourth ligand W1 is fixed by
hydrogen bonds with the side chain oxygens of Glu-133 and a water
molecule W2. The side chain of Gln-50, although it comes close to W1,
is oriented in such a way that it cannot form a reasonable hydrogen
bond with W1. In fact, there is no accepting group for the second
proton of W1 in our structure, which leads us to speculate that it
could well be a hydroxyl anion instead of a water molecule. The side chain of the conserved Gln-50 forms hydrogen bonds donating protons to
water W2 and to the hydroxyl group of Ser-92. Interestingly, water W2,
the side chain amide of Gln-50, and the main chain amide of Leu-91 are
found in the arrangement required for the tetrahedral transition state,
if W2 were replaced by the carbonyl oxygen of the formyl group. The
amides of Gln-50 and Leu-91 could well serve as an anion trap to
compensate the negative charge developing at the formyl oxygen.
|
|
|
1
were found, whereas the apparent KM values increased linearly from 4.1 mM (without PEG-1000) to 12.5 mM
(with 10 mM PEG-1000), yielding a calculated
KI value of 6 mM. The observed pattern shows that inhibition by PEG-1000 is competitive with respect
to formyl-Met.
| |
DISCUSSION |
|---|
|
|
|---|
Since its discovery about 30 years ago PDF is known to rapidly lose its activity, which makes its purification difficult (2, 23). Even in recent work with the recombinant enzyme, specific activities have been reported that are off by orders of magnitude (6, 24). Meanwhile, it has been shown that PDF is a Fe2+ enzyme (11, 12) instead of a zinc metalloprotease as previously believed (8). Whereas the Zn2+ form is nearly inactive (11, 12), we routinely observe 1200 units/mg specific activity for PDF-Fe2+ and 900 units/mg for PDF-Ni2+ (11).
The three structures now known appear to be generally similar although
significant differences remain that could well be of importance for
understanding the enzyme mechanism. The two zinc structures (8, 13)
have been compared previously (13), and the following discussion
focuses on the differences between the zinc and nickel structures
determined by x-ray analysis. These differences include Pro-9, which is
in a cis-conformation as well as two of the three
310 helices, Glu-11-Arg-14 and Phe-142-Tyr-145, which
have been modeled as
-helices
1 and
4
in the zinc structure (13). Other structural differences are found in
the region Glu-87-Leu-99, which includes the
-ribbon. In the active
site region the fourth metal ligand corresponding to W1 seems to be
displaced, and the important water molecule W2 appears to be absent
from the zinc structure. Also, the side chain of Gln-50 is more
involved in stabilizing W2 rather than W1, and the amide hydrogens of
Leu-91 and Ala-47 are found at distances 5 and 4.6 Å from W1,
respectively, which is too far for a hydrogen bond as reported
previously (13).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Karin Fritz-Wolf, Arnon Lavie, and Klaus Scheffzek for critical discussions and help at various stages of the project, Hans Wagner for excellent maintenance of the x-ray facilities at the MPI Heidelberg, and Ken Holmes and Joachim Knappe for continuous support.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates (entry code 1ICJ) and structure factors (entry code R11CJSF) have been deposited in the Protein Data Bank, Brookhaven National Laboratory, Upton, NY.
¶ To whom correspondence should be addressed. Tel.: 6221-486-276; Fax: 6221-486-437; E-mail: kabsch{at}mpimf-heidelberg.mpg.de.
1 The abbreviations used are: PDF, peptide deformylase; PEG, polyethylene glycol; MOPS, 3-morpholinopropanesulfonic acid; TCEP, tris(2-carboxyethyl)phosphine; r.m.s., root mean square.
2 Groche, D., Becker, A., Schlichting, I., Kabsch, W., Schultz, S., and Wagner, A. F. V. (1998) Biochem. Biophys. Res. Commun., in press.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Ravaud, G. Stjepanovic, K. Wild, and I. Sinning The Crystal Structure of the Periplasmic Domain of the Escherichia coli Membrane Protein Insertase YidC Contains a Substrate Binding Cleft J. Biol. Chem., April 4, 2008; 283(14): 9350 - 9358. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Watters, R. N. Jones, J. A. Leeds, G. Denys, H. S. Sader, and T. R. Fritsche Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004) J. Antimicrob. Chemother., May 1, 2006; 57(5): 914 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fieulaine, C. Juillan-Binard, A. Serero, F. Dardel, C. Giglione, T. Meinnel, and J.-L. Ferrer The Crystal Structure of Mitochondrial (Type 1A) Peptide Deformylase Provides Clear Guidelines for the Design of Inhibitors Specific for the Bacterial Forms J. Biol. Chem., December 23, 2005; 280(51): 42315 - 42324. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Aufhammer, E. Warkentin, U. Ermler, C. H. Hagemeier, R. K. Thauer, and S. Shima Crystal structure of methylenetetrahydromethanopterin reductase (Mer) in complex with coenzyme F420: Architecture of the F420/FMN binding site of enzymes within the nonprolyl cis-peptide containing bacterial luciferase family Protein Sci., July 1, 2005; 14(7): 1840 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pylypenko, F. Vitali, K. Zerbe, J. A. Robinson, and I. Schlichting Crystal Structure of OxyC, a Cytochrome P450 Implicated in an Oxidative C-C Coupling Reaction during Vancomycin Biosynthesis J. Biol. Chem., November 21, 2003; 278(47): 46727 - 46733. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Smith, C. M. Petit, K. Aubart, M. Smyth, E. McManus, J. Jones, A. Fosberry, C. Lewis, M. Lonetto, and S. B. Christensen Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species Protein Sci., February 1, 2003; 12(2): 349 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sheng, C. J. Perry, and T. R. Kleyman External Nickel Inhibits Epithelial Sodium Channel by Binding to Histidine Residues within the Extracellular Domains of alpha and gamma Subunits and Reducing Channel Open Probability J. Biol. Chem., December 13, 2002; 277(51): 50098 - 50111. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Hackbarth, D. Z. Chen, J. G. Lewis, K. Clark, J. B. Mangold, J. A. Cramer, P. S. Margolis, W. Wang, J. Koehn, C. Wu, et al. N-Alkyl Urea Hydroxamic Acids as a New Class of Peptide Deformylase Inhibitors with Antibacterial Activity Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2752 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Baldwin, M. S. Harris, A. W. Yem, C. L. Wolfe, A. F. Vosters, K. A. Curry, R. W. Murray, J. H. Bock, V. P. Marshall, J. I. Cialdella, et al. Crystal Structure of Type II Peptide Deformylase from Staphylococcus aureus J. Biol. Chem., August 16, 2002; 277(34): 31163 - 31171. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Byerly, C. A. McElroy, and M. P. Foster Mapping the surface of Escherichia coli peptide deformylase by NMR with organic solvents Protein Sci., July 1, 2002; 11(7): 1850 - 1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Margolis, C. Hackbarth, S. Lopez, M. Maniar, W. Wang, Z. Yuan, R. White, and J. Trias Resistance of Streptococcus pneumoniae to Deformylase Inhibitors Is Due to Mutations in defB Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2432 - 2435. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M.A. Dirk, M. A. Williams, and R. L. Houtz Eukaryotic Peptide Deformylases. Nuclear-Encoded and Chloroplast-Targeted Enzymes in Arabidopsis Plant Physiology, September 1, 2001; 127(1): 97 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Clements, R. P. Beckett, A. Brown, G. Catlin, M. Lobell, S. Palan, W. Thomas, M. Whittaker, S. Wood, S. Salama, et al. Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase Inhibitor Antimicrob. Agents Chemother., February 1, 2001; 45(2): 563 - 570. [Abstract] [Full Text] |
||||
![]() |
P. S. Margolis, C. J. Hackbarth, D. C. Young, W. Wang, D. Chen, Z. Yuan, R. White, and J. Trias Peptide Deformylase in Staphylococcus aureus: Resistance to Inhibition Is Mediated by Mutations in the Formyltransferase Gene Antimicrob. Agents Chemother., July 1, 2000; 44(7): 1825 - 1831. [Abstract] [Full Text] |
||||
![]() |
P. T. R. Rajagopalan and D. Pei Oxygen-mediated Inactivation of Peptide Deformylase J. Biol. Chem., August 28, 1998; 273(35): 22305 - 22310. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |